Baker Pharmaceuticals
Sarna News
- HEXTECH Review - Wave 3 Brings More Urban Options To Your Battlefield
- Your BattleTech News Round-Up For March, 2024
- Crashing 'Mechs With Jennifer Brozek, Author Of The Rogue Academy Trilogy
- Getting The Word Out With Rem Alternis, Catalyst Community & Marketing Director
- Bad 'Mechs - Yeoman
- Read more →
Baker Pharmaceuticals was a pharmaceutical company in the Lyran Commonwealth, with its assets eventually acquired by the mammoth Nashan Diversified. [1] [2]
Company Profile
Commonwealth Stock Exchange Symbol: BakPhar. [1]
Home Office: New Benner, Baker 3 (circa 3024).[1]
President/CEO: John Sleeth (circa 3024).[1]
Overview
Baker Pharmaceuticals had been in business with the Lyran Commonwealth for many years but encountered serious financial and personnel problems after losing a 300-million S-Bill lawsuit in 3023 when a batch of their synthetic molecular antibodies went toxic, killing over 100 Lyran Commonwealth Armed Forces soldiers. Like a shark smelling blood in the water, Nashan Diversified launched a takeover attempt in 3024, which Baker CEO John Sleeth attempted to resist by ordering his brokers to buy back all public Baker stocks at a substantially higher price than Nashan's offer.[1]
While saving the company in the short-term, the heavy financial burden of the buy-back forced BP to cut costs and let go staff, leaving it in dire straits with many observers questioning if the company would survive beyond 3025.[1] Nashan would ultimately succeed in acquiring Baker Pharmaceuticals, but rather than reorganize and integrate the company's Baker 3 headquarters into the Nashan family, Nashan chose to virtually liquidate BP and transfer its remaining assets to Nashan's newer Donegal offices to serve as its Nashan Pharmaceuticals division.[2]